Free Glaucoma Medication – Limited Time Offer
We are excited to announce a limited time offer that will allow patients to receive Allergan Glaucoma Medications at no cost. Thanks to the pharmaceutical giant Allergan, the medications that are being offered at no cost are as follows: LUMIGAN COMBIGAN ALPHAGANA This program is good from now until December 2015. Get your prescriptions in […]
HIV Drugs May Fight Geographic Atrophy
Some of the same antiretroviral drugs that brought hope into the lives of HIV-infected patients might now be poised to do the same for a completely new group: people who are slowly going blind from retinal geographic atrophy (GA). A multinational research team recently published a report on this intriguing and potentially revolutionary therapeutic approach,1 […]
Woman Becomes First British Person To Receive Stem Cell Treatment For Most Common Form Of Blindness
A woman has become the first person in the UK to receive treatment using stem cells for age-related macular degeneration (AMD), the most common form of blindness. The procedure was carried out by surgeons at Moorfields eye hospital in London, following research by scientists at University College London. A further nine patients will be treated over […]
Association Between Serum 25-hydroxyvitamin D Levels and Age-Related Cataracts.
Purpose To investigate associations between serum 25-hydroxyvitamin D levels and age-related cataracts. Setting Department of Ophthalmology, College of Medicine, Catholic University of Korea, South Korea. Design Observational cross-sectional study. Methods Participants aged 40 years or older in the fourth (2008 to 2009) and fifth (2010 to 2012) Korea National Health and Nutrition Examination Survey (KNHANES) had evaluation […]
Increased Cataract-Related Complications Seen In Previously Injected Eyes
Retrospective analysis of Duke Eye Center records and U.S. Medicare claims data showed a higher rate of cataract surgery-related complications in eyes that previously underwent intravitreal injections. The Duke study identified 197 eyes with history of prior intravitreal injection in 10,105 cataract surgeries performed, and compared them with an equal number of control eyes, matched […]
Association between Smoking and Uvetis
Association between Smoking and Uvetis: Results from the Pacific Ocular Inflammation Study. PURPOSE: To assess whether cigarette smoking is associated with the development of uveitis in a population-based setting. DESIGN: Retrospective, population-based, case-control study. PARTICIPANTS: Patients aged ≥ 18 years who were seen at a Kaiser Permanente Hawaii clinic between January 1, 2006, and December […]
Ten Things I Want My Patients to Know About Laser Trabeculoplasty
As a glaucoma specialist who watches patients on a daily basis struggle with the use of eye drops for glaucoma, I am an advocate for selective laser trabeculoplasty (SLT). I discuss the merits of this therapy with my patients, and I am often surprised at the amount of resistance. From now on, I will ask […]
Amlodipine, Marginal Pupil Dilation Correlation Explored in Research
Amlodipine, Marginal Pupil Dilation Correlation Explored in Research Iris-dilating rings may be needed in certain cases to enlarge pupil, ease cataract surgery Instillation of a calcium channel blocker, amlodipine (Norvasc, Pfizer), into the eye may complicate phacoemulsification by causing marginal dilation of the pupil. In such cases, pupil-dilating devices may facilitate cataract removal, said Matthew […]
Cataract Surgery in Patients with Bilateral Advanced Age-Related Macular Degeneration (AMD)
Measurement of visual acuity and quality of life PURPOSE: To measure the change in visual acuity and vision-related quality of life in patients with both age-related cataract and bilateral age-related macular degeneration (AMD) after cataract surgery. SETTING: Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China. DESIGN: Prospective case series. METHODS: Patients […]
Tyrogenex Studies Oral Treatment for Wet AMD
Tyrogenex studies oral treatment for wet AMD. Tyrogenex (West Palm Beach, FL) said it has initiated a phase 2 clinical trial for its X-82 anti-VEGF/anti-PDGF oral therapy for patients previously treated for wet AMD. The 132-patient, 52-week “APEX” study, to be conducted at 20 US and five UK sites, has dual endpoints of improved visual […]